Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
Bupropion-Related Visual Hallucinations in a Veteran With Posttraumatic Stress Disorder and Multiple Sclerosis.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Movement disorders in multiple sclerosis.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
A Simple Sign for Recognizing Off-Axis OCT Measurement Beam Placement in the Context of Multicentre Studies.
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Neural stem cell diversity and proteomics.
Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.
CD14 is a key organizer of microglial responses to CNS infection and injury.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Neuroplasticity and functional recovery in multiple sclerosis.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Activated microglia enhance neurogenesis via trypsinogen secretion.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.

Pages